Click here to download

Anti-coronavirus vaccines: an updated summary A race against time, but run necessarily observing the immunobiology rules
Journal Title: PNEI REVIEW 
Author/s: Mauro Bologna 
Year:  2020 Issue: Language: Italian 
Pages:  6 Pg. 26-31 FullText PDF:  285 KB
DOI:  10.3280/PNEI2020-001003
(DOI is like a bar code for intellectual property: to have more infomation:  clicca qui   and here 


The numerous ongoing research programs aimed at finding and producing rapidly an effective anti-coronavirus vaccine require some explanations about the vaccine immunobiology principles. In this article, the fundamental concepts of modern vaccine preparation are summarized and some of the main research initiatives in vaccine production are illustrated. The author hopes that positive results may emerge soon, allowing the solution of the current coronavirus pandemics emerged at the end of 2019 and still ongoing worldwide.
Keywords: Vaccines, Coronavirus, Virus nCoV-SARS-2, Pandemics, CoVid-19, Immunobiology.

  1. Bongini J. (2020). Coronavirus: the first batch of the vaccine will be manufactured in Pomezia, Rome, Italy. -- Testo disponibile al sito: https://www.irbm.com/web-review/coronavirus-prime-mille-dosi-del-vaccino-saranno-prodotte-a-pomezia/, visitato il 14/05/2020.
  2. Callaway E. (2020). The race for coronavirus vaccines: a graphical guide. Nature, 580: 576-577.
  3. Moderna (2020). Moderna’s Work on a Potential Vaccine Against COVID-19. -- Testo disponibile al sito: https://www.modernatx.com/modernas-work-potential-vaccine-against-covid-19, visitato il 14/05/2020.
  4. TrialSite News (2020). CanSino Biologics’ Ad5-nCoV the First COVID-19 Vaccine to Phase II Clinical Trials. -- Testo disponibile al sito: https://www.trialsitenews.com/cansino-biologics-ad5-ncov-the-first-covid-19-vaccine-to-phase-ii-clinical-trials/, visitato il 14/05/2020.
  5. Tricou V., Sáez-Llorens X., Yu D., Rivera L., Jimeno J., Villarreal A.C., Dato E., Saldaña de Suman O., Montenegro N., DeAntonio R., Mazara S., Vargas M., Mendoza D., Rauscher M., Brose M., Lefevre I., Tuboi S., Borkowski A., and Wallace D. (2020). Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2-17 years: a randomised, placebo-controlled, phase 2 trial. Lancet, 395(10234): 1434-1443., DOI: 10.1016/S0140-6736(20)30556-

Mauro Bologna, Anti-coronavirus vaccines: an updated summary A race against time, but run necessarily observing the immunobiology rules in "PNEI REVIEW" 1/2020, pp. 26-31, DOI:10.3280/PNEI2020-001003

   

FrancoAngeli is a member of Publishers International Linking Association a not for profit orgasnization wich runs the CrossRef service, enabing links to and from online scholarly content